Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 349

    1.

    Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, Hulley S, Barrett-Connor E.

    Ann Intern Med. 2005 May 17;142(10):813-20.PMID: 15897531 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.

    Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS.

    J Am Coll Cardiol. 2008 Jan 22;51(3):264-70.PMID: 18206734 [PubMed - indexed for MEDLINE]Related articles

    3.

    Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

    Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.

    Diabetes Care. 2003 Oct;26(10):2713-21.PMID: 14514569 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.

    McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA.

    J Am Geriatr Soc. 2006 Sep;54(9):1317-24.PMID: 16970637 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

    Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW.

    Arch Intern Med. 2002 Dec 9-23;162(22):2597-604.PMID: 12456232 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases]

    Wang W, Zhao D, Sun JY, Liu J, Qin LP, Wu ZS.

    Zhonghua Nei Ke Za Zhi. 2007 Jan;46(1):20-4. Chinese. PMID: 17331382 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

    Ann Intern Med. 2003 Jan 7;138(1):1-9.PMID: 12513038 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.

    Vaidya D, Kelemen MD, Bittner V, Tardif JC, Thompson P, Ouyang P.

    J Womens Health (Larchmt). 2007 Mar;16(2):228-34.PMID: 17388739 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.

    Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC.

    Arch Intern Med. 2005 Jan 24;165(2):227-33.PMID: 15668371 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.

    Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, Savage PJ, Carlson M.

    J Am Coll Cardiol. 2004 Jun 16;43(12):2236-41.PMID: 15193686 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke.

    Vermeer SE, Sandee W, Algra A, Koudstaal PJ, Kappelle LJ, Dippel DW; Dutch TIA Trial Study Group.

    Stroke. 2006 Jun;37(6):1413-7. Epub 2006 Apr 20.PMID: 16627787 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.

    Nair GV, Chaput LA, Vittinghoff E, Herrington DM; Heart and Estrogen/Progestin Replacement Study Investigators.

    Chest. 2005 May;127(5):1498-506.PMID: 15888820 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Summaries for patients. Are high sugar levels associated with new cardiovascular events in postmenopausal women who have already had a heart attack?

    [No authors listed]

    Ann Intern Med. 2005 May 17;142(10):I32. No abstract available. PMID: 15897527 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.

    Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K; ONTARGET/TRANSCEND Investigators.

    Circulation. 2007 Mar 20;115(11):1371-5. Epub 2007 Mar 5.PMID: 17339550 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

    Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M.

    Diabetes. 1997 Aug;46(8):1354-9.PMID: 9231662 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women.

    Lawlor DA, Fraser A, Ebrahim S, Smith GD.

    PLoS Med. 2007 Aug;4(8):e263.PMID: 17760500 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

    Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM.

    Arch Intern Med. 2002 Jan 28;162(2):209-16.PMID: 11802755 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data